Return of All Materials. Executive agrees that on termination or expiration of his employment with the Company, Executive will deliver, upon request, all copies and originals of documents, CD-ROMS, diskettes, tapes and other materials containing or referring to the Confidential Information, in his possession or control. Executive will also erase and write over all Confidential Information form all his computers and his other information storage devices and media, or deliver such devices or media to Company.
Return of All Materials. Upon the termination or expiration of the Co-Promotion Agreement, Targacept shall promptly return to AstraZeneca all Co-Promoted Product samples, all Promotional Materials, and all training materials that AstraZeneca provided to Targacept pursuant to the Co-Promotion Agreement that are in the possession of, or under the control of, Targacept or its Designated Sales Forces. Targacept shall retain ownership of [********] until it submits the next annual report to the FDA with respect thereto following completion or earlier termination of the Ongoing Ispronicline Trial.
1.1 Patent Territories
Return of All Materials. Upon the termination or expiration of this Agreement, AstraZeneca shall promptly return to Abraxis all Product samples, all Promotional Materials, and all training materials that Abraxis provided to AstraZeneca pursuant to this Agreement that are in the possession of, or under the control of, AstraZeneca or its Designated Sales Forces.
Return of All Materials. Upon the termination or expiration of the Co-Promotion Agreement, Targacept shall promptly return to AstraZeneca all Co-Promoted Product sample forms, all Promotional Materials, and all training materials that AstraZeneca provided to Targacept pursuant to the Co-Promotion Agreement that are in the possession of, or under the control of, Targacept or its Designated Sales Force(s).
Return of All Materials. Upon the expiration or earlier termination of this Agreement, Cubist shall destroy or promptly ship or otherwise provide to AstraZeneca all Promotional Materials, training materials and other materials (including Sales Training Materials and CSD Training Materials) including any and all copies, in any form, of any of the foregoing made by or on behalf of Cubist or its Affiliates or AstraZeneca, in Cubist’s possession or control (including those in the possession of any Program Employee, Affiliate or printer of Cubist). Cubist shall ensure that all electronic copies of any of the foregoing within Cubist’s possession or control (including those *Confidential Treatment Requested. Omitted portions filed separately with the Commission. in the possession of any Program Employee) are deleted; provided that Cubist may retain, for archival purposes only, electronic copies made as routine back-ups in accordance with Cubist’s standard operating procedures and one copy of other materials in non-electronic form by Cubist’s general counsel solely for archival purposes. Notwithstanding anything contained herein, (a) Cubist shall not have any obligation to return any such materials that contain the Cubist Trademarks, but shall not use, and shall ensure that all such materials are destroyed, and (b) with respect to all materials relating to the Promotion of the Product in the Territory in AstraZeneca’s or any of its Affiliate’s possession or control that contain any Cubist Trademark, AstraZeneca shall not use such materials and shall ensure that all such materials are destroyed.
Return of All Materials. Upon the termination or expiration of the Co-Promotion Agreement, MAP shall promptly return to AstraZeneca all Licensed Product samples (if any), all Promotional Materials, and all training materials that AstraZeneca provided to MAP pursuant to the Co-Promotion Agreement that are in the possession of, or under the control of, MAP or the MAP Specialist Sales Force. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Date: Parties:
(1) ‘The Licensor’: having its registered office at .
(2) ‘The Licensee’: having its registered office at .
Return of All Materials. (a) Upon the termination or expiration of this Agreement or, if applicable, the Sell-Off Period, Distributor shall, and shall cause its Representatives to, promptly return to SWAI all Product samples supplied by SWAI and in the possession or control of Distributor or the Representatives, all Detailing and Promotional Materials, and all training materials that SWAI provided to Distributor pursuant to this Agreement that are in the possession of, or under the control of, Distributor or the Representatives.
(b) Upon the termination or expiration of this Agreement, SWAI shall promptly return to Distributor all training materials that Distributor provided to SWAI pursuant to this Agreement that are in the possession of, or under the control of, SWAI.
Return of All Materials. At the end of the Term, the Company shall promptly return to AZ all Product samples, all equipment and materials, Promotional Materials, and training materials that AZ provided to the Company in connection with the Program or otherwise pursuant to this Agreement in the possession of, or under the control of, the Company or the Company Sales Force; provided the Company shall have the right to purchase the lap top and Territory Management Devices from AZ at their respective then fair market value.
Return of All Materials. Upon termination of this Agreement or any Statement of Work, MDSPS shall return all Study Materials, documentation, data, reports and any other item related to a Project or the Services rendered to Sponsor upon request, except for those materials or copies thereof that are required by law or regulation to be retained by MDSPS.
Return of All Materials. Upon the expiration or earlier termination of this Agreement, MDCO shall, at AstraZeneca's election and expense, promptly (a) return to AstraZeneca or (b) destroy and certify to AstraZeneca such destruction, all Promotional Materials and training materials for the Product that AstraZeneca provided to MDCO pursuant to this Agreement and in the possession of, or under the control of, MDCO.
